Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibodies Against Nogo-A to Enhance Plasticity, Regeneration and Functional Recovery After Spinal Cord Injury - A Multicenter International Randomized Double Blind Placebo Controlled Phase II Clinical Proof of Concept Trial

NCT03935321 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT03935321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03935321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibodies Against Nogo-A to Enhance Plasticity, Regeneration and Functional Recovery After Spinal Cord Injury - A Multicenter International Randomized Double Blind Placebo Controlled Phase II Clinical Proof of Concept Trial
Lead sponsor
University of Zurich
Phase
Phase 2
Overall status
Completed
Start date
May 15, 2019
Completion date
February 2, 2023
Enrollment
129 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury, acute